CI 10-Q Quarterly Report Sept. 30, 2022 | Alphaminr
ALPHAMINR

CI 10-Q Quarter ended Sept. 30, 2022

Balance Sheet
Cash Flow
Income Statement
Debt
TABLE OF CONTENTS
Part IItem 1. Financial StatementsNote 1 Description Of BusinessNote 2 Summary Of Significant Accounting PoliciesNote 3 Accounts Receivable, NetNote 4 Mergers, Acquisitions and DivestituresNote 5 Assets and Liabilities Of Businesses Held For SaleNote 6 Earnings Per Share ("eps")Note 7 DebtNote 8 Common and Preferred StockNote 9 Insurance and Contractholder LiabilitiesNote 10 ReinsuranceNote 11 InvestmentsNote 12 Fair Value MeasurementsNote 13 Variable Interest EntitiesNote 14 Accumulated Other Comprehensive Income (loss) ("aoci")Note 15 Organizational Efficiency PlanNote 16 LeasesNote 17 Income TaxesNote 18 Contingencies and Other MattersNote 19 Segment InformationItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationPart IIItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 5. Other InformationItem 6. Exhibits

Exhibits

3.2 Restated By-Laws of Cigna Corporation dated October 26, 2022 Filed by the registrant as Exhibit 3.2 to the Current Report on Form 8-K on October 28, 2022 and incorporated herein by reference. 31.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 Filed herewith. 31.2 Certification of Chief Financial Officer of Cigna Corporation pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 Filed herewith. 32.1 Certification of Chief Executive Officer of Cigna Corporation pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 Furnished herewith. 32.2 Certification of Chief Financial Officer of Cigna Corporation pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350 Furnished herewith.